Skip to main content Accessibility help


  • SA Duursma (a1), JA Raymakers (a1), BAA Scheven (a1) and PAF Jansen (a1)


  • An abstract is not available for this content so a preview has been provided below. Please use the Get access link above for information on how to access this content.


Corresponding author

SA Duursma, Department of Geriatrics, University Hospital Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands.


Hide All
1Albright, FA, Reifenstein, ED.The parathyroid glands and metabolic bone disease. Baltimore: Williams & Wilkins, 1948.
2Riggs, BL, Melton, LJ.Osteoporosis, etiology, diagnosis and management. New York: Raven Press, 1988.
3Riggs, BL, Melton, LJ.The prevention and therapy of osteoporosis. N Engl J Med 1992; 327: 620–27.
4Cooper, C, Atkinson, EJ, O'Fallon, WM, Melton, LJ.The incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res 1992; 7: 221–27.
5Cooper, C, Shah, S, Hand, DJ, Compston, J, Davie, M.Screening for osteoporosis using individual risk factors. Osteoporosis Int 1991; 2: 4853.
6Cooper, C.Vertebral fractures. How large is the silent epidemic? Br Med J 1992; 304: 793–94.
7Resnick, NM, Greenspan, SL.‘Senile’ osteoporosis reconsidered. JAMA 1989; 261: 1025–29.
8Van, Os C.Transcellular calcium transport in intestinal and renal epithelial cells. Biochem Biophys Acta 1987; 906: 195–22.
9Bronner, F. Calcium absorption. In: Johnson, LR ed. Physiology of the gastrointestinal tract, second edition. New York: Raven Press, 1987: 1419–34.
10Heersche, JNM. Bone cells and bone turnover; the basis for pathogenesis. In: Tarn, CS, Heersche, JNM, Murray, TM eds. Metabolic bone disease: cellular and tissue mechanism. Boca Raton: CRC Press, 1989: 119.
11Hodgson, SF.Corticosteroid-induced osteoporosis. Endocrinol Metab Clin North Am 1990; 19: 95112.
12Duursma, SA, Slootweg, MC, Bijlsma, JWJ. How does oestrogen prevent postmenopausal osteoporosis? In: Bergener, M, Ermini, M, Stāhelin, HB eds. Crossroads in aging. Academic Press, 1988: 169–80.
13Reginster, TY, Deroisy, R, Albert, A.Relationship between whole plasma calcitonin levels, calcitonin secretion capacity, and plasma levels of estron in healthy women and postmenopausal osteoporotics. J Clin Invest 1989; 83: 1073–77.
14Tørring, O, Bucht, E, Sjöberg, HE.The influence of sex steroid hormones on plasma calcitonin response to the calcium clamp in normal subjects. J Bone Miner Res 1987; 2: 407–11.
15Feyen, JHM, Raisz, LG.Prostaglandin production by calvaria from sham operated rats: effect of 17 '-estradiol in vivo. Endocrinology 1987; 121: 819–21.
16Duursma, SA, Jaszmann, LBJ, De Raadt, ME, Van Rhijn, HJM, Wit, JM, Raymakers, JA. Changes in insulin-like growth factor-I and growth hormone and prevention of bone loss during oestrogen replacement therapy. Growth Regulation 1992 (in press).
17McCarthy, TL, Centrella, M, Canalis, E.Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures. Endocrinology 1989; 124: 301309.
18Scheven, BAA, Hamilton, NJ.Stimulation of macrophage growth and induction of multinucleated cell formation in rat bone marrow cultures by insulin-like growth factor. Biochem Biophys Res Commun 1992; 174: 647–53.
19Slootweg, MC, Hermann-Erlee, MPM, Van der Meer, JM, Duursma, SA.Fetal mouse osteoblasts respond to physiological concentrations of growth hormone and produce insulin-like growth factors. Calcif Tissue Int 1987; 46 (suppl): OP11.
20Slootweg, MC, Otte, AP, Van Genesen, AP, Duursma, SA, Kuijer, W.Signal transduction of mouse osteoblast growth hormone receptor: independent of phosphoinositide breakdown and c-AMP. J Bone Miner Res 1989; 4 (suppl): S340.
21Scheven, BAA, Damen, CA, Hamilton, NJ, Verhaar, HJJ, Duursma, SA.Stimulatory effects of estrogen and progesterone on proliferation and differentiation of normal human osteoblast-like cells in vitro. Biochem Biol Res Commun 1992; 186: 5460.
22Jilka, RL, Hangoc, G, Girasolr, G et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992; 257: 8991.
23Tobias, JH, Chambers, TJ.The effect of sex hormones on bone resorption by rat osteoclasts. Acta Endocrinol (Copenh) 1991; 124: 121–27.
24Mosekilde, L, Eriksen, EF, Charles, P.Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North 1990; 19: 3564.
25Parisien, M, Silverberg, SJ, Shane, E, Dempster, DW, Bilezikian, JP.Bone disease in primary hyperthyroidism. Endocrinol Metab Clin North Am 1990; 19: 1934.
26Baillie, SP, Davidson, CE, Johnson, FJ, Francis, RM.Pathogenesis of vertebral crush fractures in men. Age Ageing 1992; 21: 139–41.
27Jackson, JA, Riggs, MW, Spiekerman, AM.Testosterone deficiency as a risk factor for hip fractures in men: a case-control study. Am J Med Sci 1992; 304: 48.
28Rudman, D, Feller, AG, Cohn, L, Shetty, KR, Rudman, IW, Draper, MW.Effects of human growth hormone on body composition in elderly men. Horm Res 1991; 36: 7381.
29Duursma, SA, Raymakers, JA. Osteoporosis and exercise. In: Hermans, GPH, Mosterd, WL eds. Sports, medicine and health. Amsterdam: Elsevier, 1990: 119–28.
30Blumenthal, JA, Emery, CF, Madden, DJ et al. Effects of exercise training on bone density in older men and women. J Am Geriatr Soc 1991; 39: 1065–70.
31McKenna, MJ.Differences in vitamin D status between countries in young adults and the elderly. Am J Med 1992; 93: 6977.
32McMurthy, CT, Young, SE, Downs, RW, Adler, RA.Mild vitamin D deficiency and secondary hyperparathyroidism in nursing home patients receiving adequate dietary vitamin D. J Am Geriatr Soc 1992; 40: 343–47.
33Lips, P, Van Ginkel, FC, Jongen, MJ.Determinants of vitamin D status in patients with hip fracture and elderly control subjects. Am J Clin Nutr 1987; 46: 1005–10.
34Zetterberg, C, Mannius, S, Melstrom, D, Rundgren, A, Astrand, K.Osteoporosis and back pain in the elderly. A controlled epidemiologic and radiographic study. Spine 1990; 15: 783–86.
35Finsen, V.Osteoporosis and back pain among the elderly. Acta Med Scand 1988; 223: 443–49.
36Leidig, G, Minne, HW, Sauer, P, Wüster, C, Wüster, L, Lojen, M.A study of complaints and their relation to vertebral destruction in patients with osteoporosis. Bone Miner 1990; 8: 217–29.
37Christiansen, C, Riis, BJ, Rodbro, P.Prediction of rapid bone loss in postmenopausal women. Lancet 1987; i: 11051108.
38Melton, LJ, Kan, SH, Wahner, HW, O'Fallon, WM.Riggs, BL.Epidemiology of vertebral fractures in women. Am J Epidemiol 1989; 129: 1000–11.
39Ross, PD, Wasnich, RD, Vogel, JM.Detection of prefracture spinal osteoporosis using bone mineral absortiometry. J Bone Miner Res 1988; 3: 111.
40Eastell, R, Cedel, SL, Wahner, HW, Riggs, BL, Melton, LJ.Classification of vertebral fractures. J Bone Miner Res 1991; 6: 207–15.
41Conference Report. Consensus development conference: prophylaxis and treatment of osteoporosis. Osteoporosis Int 1991; 1: 114–17.
42Dequeker, J, Geusens, P.Treatment of established osteoporosis and rehabilitation: current practice and possibilities. Maturitas 1990; 12: 136.
43Kanis, JA, Passmore, R.Calcium supplementation of the diet: not justified by present evidence. Br Med J 1989; 298: 205208.
44Nordin, BEC, Heaney, RP.Calcium supplementation of the diet: justified by present evidence. Br Med J 1990; 300: 1056–60.
45Elders, PJM, Netelenbos, JC, Lips, P.Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age. J Endocrinol Metab 1991; 73: 533–40.
46Lindsay, R, Thome, JF. Estrogen treatment with established postmenopausal osteoporosis. Obstet Gynecol 1990; 76: 290–95.
47Lufkin, EG, Wahner, HW, O'Fallon, WM, Hodgson, WF, Kotowicz, MA, Lane, AW.Treatment of osteoporosis by transdermal estrogen administration. Ann Intern Med 1992; 117: 19.
48Ott, SM.Estrogen therapy for osteoporosis. Even in the elderly. Ann Intern Med 1992; 117: 8586.
49Need, AG, Horowitz, M, Walker, CJ, Chatterton, BE, Chapman, IC, Nordin, BEC.Cross-over study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis. Bone 1987; 10: 36.
50Hassager, C, Riis, BJ, Podenphant, J, Christiansen, C.Nandrolone decanoate treatment of postmenopausal osteoporosis for two years and effects of withdrawal. Maturitas 1989; 11: 305–17.
51Johansen, JS, Hassager, C, Podenphant, J.Treatment of postmenopausal osteoporosis. Is anabolic steroid nandrolone decanoate a candidate? Bone Miner 1989; 6: 7786.
52Lyritis, GP, Tsakalakos, N, Magiasis, B, Karachalios, B, Yiatzides, A, Tsekoura, M.Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double blind placebo controlled clinical study. Calcif Tissue Int 1991; 49: 369–72.
53Civitelli, R, Gonelli, S, Zacchei, F.Bone turn-over in postmenopausal osteoporosis: effect of calcitonin treatment. J Clin Invest 1988; 82: 1268–74.
54Reginster, JY, Dennis, D, Albert, A.1-year controlled randomization trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancel 1987; ii: 1481–83.
55Reginster, JY.Effect of calcitonin on bone mass and fracture rate. Am J Med 1991; 91: 1922.
56Overgaard, K, Riis, BJ, Christiansen, C, Hansen, MA.Effect of calcitonin given intranasally on early postmenopausal bone loss. Br Med J 1989; 299: 477–79.
57Ringe, JD, Welzel, D.Salmon calcitonin in the therapy of corticoid-induced osteoporosis. Eur J Pharmacol 1987; 33: 3539.
58Storm, T, Thamsborg, G, Steiniche, T, Genant, HK, Sørensen, OH.Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 1990; 322: 1265–71.
59Watts, NB, Harris, ST, Genant, HK, Wasnich, RD, Miller, PD, Jackson, RD. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 1990; 323: 7379.
60Reid, IR, King, AR, Alexander, CJ, Ibbertson, HK. Prevention of steroid-induced osteoporosis with (3 amino-1-hydroxypropylidene)-1, 1-bisphosphonate (APD). Lancet 1988; i: 143–46.
61Lau, HW, Farley, JR, Baylink, DJ. Molecular mechanism of the mitogenic action of fluoride: inhibition of osteoblastic acid phosphatase-like phosphotyrosyl protein phosphatase activity. In: Christiansen, C, Johansen, JS, Riis, BJ eds. Osteoporosis 1987. Copenhagen: Osteopress ApS, 1987: 824–28.
62Kappelle, JW. Effects of 24,25 dihydroxycholecalciferol in healthy subjects and patients treated with fluoride for osteoporosis [Thesis]. Utrecht, 1991.
63Duursma, SA, Raymakers, JA, De Raadt, ME, Karsdorf, MJGH, Van Dijk, A, Glerum, J.Urinary fluoride excretion in responders and nonresponders after fluoride therapy in osteoporosis. J Bone Miner Res 1990; 5 (suppl 1): S4347.
64Pak, CYC, Sakhaee, K, Zerwekh, JE, Parcel, C, Peterson, R, Johnson, K.Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone loss and inhibition of fractures. J Clin Endocrinol Metab 1990; 68: 150–59.
65Delmas, PD, Dupuis, J, Duboeuf, F, Chapuy, MC, Meunier, PJ.Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride. J Bone Miner Res 1990; 5 (suppl 1): S143–47.
66Riggs, BL, Hodgson, SF, O'Fallon, WF.Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990; 322: 802809.
67Kleerekoper, M, Peterson, EL, Nelson, DA.A randomized trial of sodium fluoride as a treatment postmenopausal osteoporosis. Osteoporosis Int 1991; 1: 155–61.
68Mamelle, N, Meunier, PJ, Netter, P.Fluoride and vertebral fractures. Lancet 1990; i: 336–43.
69Canalis, E, Centrella, M, Burch, W, McCarthy, TL.Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone culture. J Clin Invest 1989; 83: 6065.

Related content

Powered by UNSILO


  • SA Duursma (a1), JA Raymakers (a1), BAA Scheven (a1) and PAF Jansen (a1)


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.